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Abstract 1 
The bioaccessibility of phenolic compounds after in vitro gastro-intestinal digestion of dark 2 
chocolate, dark chocolate enriched with Sakura green tea and dark chocolate enriched with turmeric 3 
powder was studied. The phenolic profile, assessed by accurate mass spectrometry analysis, was 4 
modified during in vitro gastro-intestinal digestion, with a considerable decrease of total and 5 
individual phenolic compounds. Phenolic acids showed the highest bioaccessibility with 6 
hydroxycinnamic acids displaying higher bioaccessibility (from 41.2% to 45.1%) respect to 7 
hydroxybenzoic acids (from 28.1% to 43.5%). Isomerisation of caffeoyl-quinic acids and galloyl-8 
quinic acids as well as dimerization of (epi)gallocatechin were also observed after in vitro gastro-9 
intestinal digestion. Antioxidant activity increased after the gastric step and rose further at the end 10 
of the digestion. Furthermore, in vitro digested phenolic-rich fractions showed anti-proliferative 11 
activity against two models of human colon adenocarcinoma cell lines. Cell metabolism of digested 12 
phenolic compounds resulted in the accumulation of coumaric and ferulic acids in the cell media. 13 
 14 
Keywords: mass spectrometry, in vitro digestion, cell metabolism, functional foods, Caco-2, 15 
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1. Introduction 17 
Cocoa and cocoa-based products, such as dark chocolate, are widely consumed in several countries 18 
and significantly contribute to the daily intake of antioxidants and phenolic compounds in adults 19 
and children (Rusconi, & Conti). Recently, our research group comprehensively analysed the 20 
phenolic profile of dark chocolate (Martini, Conte, & Tagliazucchi, 2018). More than 140 21 
individual phenolic compounds were identified by accurate mass spectrometry analysis. Flavan-3-22 
ols are the most abundant phenolic compounds in dark chocolate, accounting for around the 64% of 23 
total phenolics (Martini et al., 2018).  24 
There are several in vivo studies suggesting that cocoa-derived polyphenols may have beneficial 25 
effects on markers of cardiovascular disease risk (Del Rio et al., 2013). Short-term randomized 26 
clinical trials have demonstrated that dark chocolate intake reduced blood pressure, improved flow-27 
mediated dilation and ameliorated the lipid profile in healthy and hypertensive subjects (Grassi, 28 
Lippi, Necozione, Desideri, & Ferri, 2005a; Grassi et al., 2005b; Lin et al., 2016). These effects 29 
have been partially attributed to the high flavan-3-ols content of dark chocolate (Engler et al., 30 
2004). Furthermore, dark chocolate intake has been shown to reduce the number of pre-neoplastic 31 
lesions in azoxymethane-induced colonic cancer in rats (Hong, Nulton, Shelechi, Hernández, & 32 
Nemposeck, 2013; Rodríguez-Ramiro et al., 2011a). The protective effect of dark chocolate against 33 
colon cancer may be due to the biological activities of its phenolic compounds through the 34 
regulation of several signal transduction pathways and the modulation of gene expression 35 
(Carnésecchi et al., 2002; Granado-Serrano et al., 2010; Martín et al., 2010; Rodríguez-Ramiro, 36 
Ramos, Bravo, Goya, & Martín, 2011b). 37 
The bioavailability of phenolic compounds differs widely among the different classes. Some 38 
phenolic compounds are poorly absorbed (Del Rio et al., 2013) and/or are unstable under the gastro-39 
intestinal tract conditions (Bouayed, Deußer, Hoffmann, & Bohn, 2012; Juániz et al., 2017). Indeed, 40 
dark chocolate phenolic compounds are entrapped in a solid food matrix and only the released 41 
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compounds are potentially bioavailable and able to exert their beneficial effects in the gastro-42 
intestinal tract or at systemic level (Tagliazucchi, Verzelloni, Bertolini, & Conte, 2010; 43 
Tagliazucchi, Verzelloni, & Conte, 2012). Therefore, studies carried out with cell culture models 44 
using pure phytochemicals (Carnésecchi et al., 2002) or cocoa/chocolate extracts (Rodríguez-45 
Ramiro, et al., 2011b) are unrealistic unless the bioaccessibility and gastro-intestinal tract stability 46 
of the phenolic compounds have been well defined. Furthermore, in vitro studies did not take into 47 
account the stability of tested molecules in cell cultures and their metabolic fate within the cells 48 
(Aragonès, Danesi, Del Rio, & Mena, 2017). 49 
This work aimed to investigate the effect of in vitro gastro-intestinal digestion on the 50 
bioaccessibility of phenolic compounds in dark chocolate and dark chocolate functionalized with 51 
Sakura green tea leaves or turmeric powder. In addition, the antioxidant and anti-proliferative 52 
activities of in vitro digested dark chocolates phenolic compounds against two models of human 53 
colonic cell lines were assessed. Finally, the last task was to identify and quantify the main 54 
metabolites derived from incubation of in vitro digested dark chocolate phenolic compounds with 55 
cells. 56 
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2. Materials and methods 57 
2.1. Materials  58 
Phenolic compound standards, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox), 59 
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,4,6-tri(2-pyridyl)-S-triazine 60 
(TPTZ), Folin-Ciocalteau phenol reagent were purchased from Sigma (Milan, Italy). Methanol and 61 
formic acid were obtained from Carlo Erba (Milan, Italy). All MS/MS reagents were from Bio-Rad 62 
(Hercules, CA, U.S.A.). Chemicals and enzymes for the digestion procedure were purchased from 63 
Sigma-Aldrich (Milan, Italy). All the materials and chemicals for cell culture were from Euroclone 64 
(Milan, Italy). MTS cell proliferation assay kit was purchased from Promega (Milan, Italy). Solid 65 
phase extraction (SPE) columns (C18, 50 μm, 60 Å, 500 mg) were supplied by Waters (Milan, 66 
Italy). Three different types of chocolate (dark 70% cocoa (DC), dark 70% cocoa and 8% turmeric 67 
(TDC), dark 70% cocoa and 2% Sakura green tea (GTDC)) were bought from a local shop in 68 
Modena (Italy). The chocolates were all from the same manufacturer and had the same composition. 69 
The ingredients were cocoa mass, sugar, cocoa butter, soya lecithin and natural flavour vanilla. 70 
GTDC and TDC were enriched with 2% Sakura green tea leaves and 8% turmeric powder, 71 
respectively. Three chocolate bars for each sample were used in this study.  72 
 73 
2.2. In vitro gastro-intestinal digestion of dark chocolates and preparation of the chemical extract 74 
For the in vitro digestion, the protocol previously developed within the COST Action INFOGEST 75 
was followed (Minekus et al., 2014). The procedure consisted of three consecutive steps: oral, 76 
gastric and intestinal phases. The three steps were carried out in absence of light. Simulated 77 
salivary, gastric, and intestinal fluids (SSF, SGF and SIF) were employed for each step and 78 
prepared according to Minekus et al. (2014). Five grams of each type of dark chocolate were melted 79 
at 37°C for 10 minutes and then 5 mL of the stock SSF solution and 150 U/mL of porcine α-80 
amylase were added (oral phase of digestion). The samples were shaken for 5 min at 37°C. The 81 
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second step of the digestion (gastric phase) was carried out by adding to the bolus 10 mL of SGF. 82 
The pH was adjusted to 2.0 with 6 mol/L HCl and supplemented with porcine pepsin (2000 U/mL 83 
of simulated gastric fluid). After 2 h of incubation at 37°C, the final intestinal step was carried out 84 
by adding 15 mL of SIF (prepared by mixing 10 mL of pancreatic fluid and 5 mL of bile salts). 85 
Then, the pH was adjusted to 7.0, supplemented with pancreatin and the samples were incubated at 86 
37°C for 2 h. All samples were immediately cooled on ice, centrifuged at 10000g for 20 min at 4°C 87 
to eliminate insoluble materials and the supernatant frozen at –80°C for further analysis. The 88 
digestions were performed in triplicate.  89 
In addition, phenolic compounds were extracted from each dark chocolate (chemical extract) as 90 
reported in Martini et al. (2018). The extractions were performed in triplicate. 91 
Dark chocolate chemical extracts and samples collected at the end of each stage of the in vitro 92 
digestion procedure were then used for total phenolic compounds and antioxidant activity 93 
determinations. 94 
 95 
2.3. Identification and quantification of phenolic compounds by liquid chromatography mass 96 
spectrometry (LC-ESI-QTOF-MS/MS) 97 
Dark chocolate chemical extracts and in vitro digested samples were analysed on Agilent HPLC 98 
1200 Infinity (Agilent Technologies, Santa Clara, CA) equipped with a C18 column (HxSil C18 99 
Reversed phase, 250×4.6 mm, 5 μm particle size, Hamilton Company, Reno, Nevada, USA) as 100 
reported in Martini et al. (2018). The mobile phases consisted of (A) H2O/formic acid (99:1, v/v) 101 
and (B) acetonitrile/formic acid (99:1, v/v). After 0.5 min at 4% B, the gradient linearly rose up to 102 
30% B in 60 min. The mobile phase composition was ramped up to 100% B in 1 min and 103 
maintained for 5 min in order to wash the column before returning to the initial condition. The flow 104 
rate was established at 1 mL/min. After passing to the column, the eluate was split and 0.3 mL/min 105 
were directed to a 6520 accurate Q-TOF mass spectrometer (Agilent Technologies, Santa Clara, 106 
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CA). Identification of phenolic compounds in all samples was carried out using full scan, data-107 
dependent MS2 scanning from m/z 100 to 1700. MS operating conditions, calibration curve 108 
equations, linearity ranges and limit of quantifications (LOQ) for the different standards are 109 
reported in Martini et al. (2018). 110 
Quantitative results were expressed as μmol of compounds per 100 g of chocolate.  111 
 112 
2.4. Total phenolic compounds and antioxidant activity assays 113 
Folin-Ciocalteau assay was performed as reported by Singleton, Orthofer, & Lamuela-Raventós 114 
(1999). The results were expressed as μmol of gallic acid per 100 g of chocolate. 115 
The antioxidant properties of dark chocolate chemical extracts and in vitro digested samples were 116 
evaluated performing two different assays. The ABTS (2,2’-azino-bis (3-ethylbenzothiazoline-6-117 
sulfonic acid) and ferric reducing power (FRAP) assays were performed according to the protocols 118 
described by Re et al. (1999) and Benzie, & Strain (1996), respectively. The ABTS scavenging 119 
capacity and FRAP values were expressed as mmol of trolox equivalent per 100 g of chocolate. 120 
 121 
2.5. Preparation of dark chocolate phenolic-rich fractions 122 
Samples collected at the end of the in vitro digestion were then passed through a SPE column 123 
preconditioned with 4 mL of acidified methanol (containing 0.1% of formic acid), followed by 5 124 
mL of acidified water (containing 0.1% of formic acid). Elution was carried out with acidified water 125 
(6 mL) to eliminate the unbound material. Phenolic compounds were then desorbed by elution with 126 
3 mL of acidified methanol. The obtained phenolic-rich extracts were diluted in the cell media and 127 
used for the anti-proliferative activity determination. Each sample was extracted in triplicate. 128 
 129 
2.6. Cell cultures and anti-proliferative activity of in vitro digested dark chocolate phenolic-rich 130 
fractions 131 
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Human adenocarcinoma Caco-2 cells were cultured in Dulbecco’s Modified Eagle’s Medium 132 
(DMEM) supplemented with 10% foetal bovine serum (FBS), 1% antibiotic mix (streptomycin and 133 
penicillin) and 2 mmol/L L-glutamine. Caco-2 cells were used for experiments between passage 57 134 
and 58. Human adenocarcinoma SW480 cells were cultured in Leibowitz medium supplemented 135 
with 10% FBS, 1% antibiotic mix (streptomycin and penicillin) and 2 mmol/L L-glutamine. SW480 136 
cells were used for experiments between passage 33 and 34. Cells were maintained at 37°C in a 137 
humidified atmosphere of 5% CO2.  138 
Cells were seeded at 5x103/100 μL and 10x103/100 μL for Caco-2 and SW480, respectively, in 96-139 
well plates 24 h before the assay to allow cell adhesion to the bottom of the wells. 140 
For the anti-proliferative assays a colorimetric method for the sensitive quantification of viable cells 141 
was performed, using MTS assay kit. Different amounts of the in vitro digested phenolic-rich 142 
fractions were diluted in cell culture media and added to the cell plates for 24 h. At the end of the 143 
treatments, the medium was refreshed with 180 μL of culture medium and 20 μL of MTS reagent 144 
were added to each well. After 4 h of incubation at 37°C, the absorbance was measured at the 145 
wavelength of 490 nm using a microplate reader and results were expressed as IC50. IC50 was 146 
defined as the concentration of phenolic compounds required to inhibit 50% cell proliferation and 147 
expressed as μmol of total phenolic compounds/100 g of chocolate. The IC50 values were 148 
determined using nonlinear regression analysis and fitting the data with the log (inhibitor) vs. 149 
response model generated by GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). The 150 
amount of phenolic compounds was determined by LC-ESI-QTOF MS/MS analysis as described in 151 
section 2.3. 152 
 153 
2.7. Liquid chromatography coupled to mass spectrometry (LC-MS/MS) analysis of cell media 154 
Caco-2 and SW480 cell lines were incubated with in vitro digested dark chocolate (DC) at a 155 
concentration corresponding to IC50. After 24 h of incubation at 37°C, cell culture supernatants 156 
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were collected and analysed by LC-MS/MS to determine the stability and the metabolism of the 157 
dark chocolate phenolic compounds in the cell media. Cell media were extracted according to Sala 158 
et al. (2015) and investigated according to Martini, Conte, & Tagliazucchi (2017). Briefly, samples 159 
were analysed using a HPLC Agilent 1200 Series system equipped with an Agilent 6300 ion trap 160 
mass spectrometer. Separations were performed using a C18 column (HxSil C18 Reversed phase, 161 
250×4.6 mm, 5 μm particle size, Hamilton Company, Reno, Nevada, USA), with an injection 162 
volume of 40 μL and elution flow rate of 1 mL/min. The mobile phase composition, the gradient 163 
and MS operating conditions are the same as reported in Martini et al. (2017). MS experiments were 164 
performed in ESI negative ion mode. Identification of phenolic compounds and metabolites in all 165 
samples was carried out using full scan, data-dependent MS2 scanning from m/z 100 to 1700. 166 
 167 
2.8. Statistic 168 
 All data are presented as mean ± SD for three replicates for each prepared sample. One-way 169 
analysis of variance (one-way ANOVA) with Tukey’s post-hoc test was applied using Graph Pad 170 
prism 6.0 (GraphPad software, San Diego, CA, U.S.A.). The differences were considered 171 
significant with P<0.05.172 
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3. Result and discussion 173 
3.1. In vitro bioaccessibility of phenolic compounds in different types of dark chocolate  174 
In our previous work we identified and quantified by high-resolution mass spectrometry 141, 155 175 
and 142 phenolic compounds in dark chocolate (DC), dark chocolate enriched with Sakura green 176 
tea (GTDC) and dark chocolate enriched with turmeric powder (TDC), respectively (Martini et al., 177 
2018). In this work, we present data regarding the release and bioaccessibility of dark chocolate 178 
total and individual phenolic compounds following in vitro gastro-intestinal digestion. Figure 1 179 
shows the impact of in vitro gastro-intestinal digestion on total phenolic compounds. The chemical 180 
extract of GTDC showed a significant higher amount (P<0.05) of total polyphenols (20090.58 ± 181 
760.92 μmol gallic acid equivalent/100 g of dark chocolate) respect to TDC (17887.63 ± 556.33 182 
μmol gallic acid equivalent/100 g of dark chocolate) and DC (15425.27 ± 660.47 μmol gallic acid 183 
equivalent/100 g of dark chocolate). After salivary phase, only 8.9%, 7.8% and 10.2% of total 184 
phenolic compounds were released from the food matrices in DC, GTDC and TDC, respectively. 185 
The amount of bioaccessible total phenolic compounds increased by 31%, 26.5% and 20.1% in DC, 186 
GTDC and TDC, respectively, after two hours of gastric digestion (Figure 1). The incubation with 187 
pancreatic solution further increased the bioaccessibility of total compounds in the different samples 188 
but to a different extent (Figure 1). At the end of the entire phase of digestion, the 68.7%, 68.2% 189 
and 40.1% of total phenolic compounds from DC, GTDC and TDC, respectively, were 190 
bioaccessible, while the remaining were degraded or not extracted from the solid matrices. From a 191 
quantitative point of view, GTDC showed a significant higher amount (P<0.05) of total 192 
bioaccessible polyphenols (13709.31 ± 377.47 μmol gallic acid equivalent/100 g of dark chocolate) 193 
respect to DC (10599.88 ± 213.43 μmol gallic acid equivalent/100 g of dark chocolate). TDC 194 
showed the lowest amount (P<0.05) of total bioaccessible phenolic compounds (7172.14 ± 512.02 195 
μmol gallic acid equivalent/100 g of dark chocolate). These results are in agreement with previously 196 
reported data showing that the gastro-intestinal tract behaved as an extractor promoting the release 197 
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of phenolic compounds from solid food matrices (Blancas-Benitez, Pérez-Jiménez, Montalvo-198 
González, González-Aguilar, & Sáyago-Ayerdi, 2018; Tagliazucchi et al., 2010; Tagliazucchi et al., 199 
2012). However, other studies found a decrease in bioaccessible total phenolic compounds during 200 
the intestinal digestion (Bouayed et al., 2012; Lingua, Wunderlin, & Baroni, 2018). The different 201 
results can be related to the higher stability of dark chocolate phenolic compounds to the intestinal 202 
conditions respect to the other foods tested or to a different food matrix effect. However, it should 203 
be taken into account that the Folin-Ciocalteau assay is strongly subject to interferences, especially 204 
from sugars and vitamin C (Singleton et al., 1999). On the other hand, dark chocolate is rich in 205 
Maillard reaction products that react in a concentration-dependent manner with the Folin-Ciocalteau 206 
reagent, possibly resulting in an overestimation of bioaccessible total phenolic compounds 207 
(Verzelloni, Tagliazucchi, & Conte, 2007).  208 
Figure 2 and Tables 1-6 show how the in vitro gastro-intestinal digestion modified the phenolic 209 
compounds profile in the samples from a qualitative and quantitative point of view. The MS data of 210 
the individual phenolic compounds are reported in Martini et al. (2018). A total of 78, 122 and 86 211 
phenolic compounds were identified by accurate mass spectrometry analysis after in vitro gastro-212 
intestinal digestion of DC, GTDC and TDC, respectively. This means that 45%, 21% and 39% of 213 
individual phenolic compounds were not bioaccessible in DC, GTDC and TDC, respectively. A 214 
significant lower amount of phenolic compounds was observed in all the samples after simulated 215 
gastro-intestinal digestion respect to the chemical extracts. In TDC, only 17.6% of the total amount 216 
of phenolic compounds was released from the food matrix or not degraded during digestion. In DC 217 
and GTDC, the amount of bioaccessible total phenolic compounds at the end of the digestion was 218 
23.0% and 23.2%, respectively (Figure 2H and Table 6).  219 
The apparent lowest bioaccessible value of phenolic compounds in TDC was ascribed to the poor 220 
bioaccessibility (0.24%) of curcuminoids (Table 4).  221 
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Among the different phenolic classes, phenolic acids showed the highest bioaccessibility (Figure 222 
2B and 2G) with hydroxycinnamic acids displaying higher bioaccessibility (from 41.2% to 45.1%) 223 
than hydroxybenzoic acids (from 28.1% to 43.5%). These compounds were efficiently released 224 
from the food matrices and stable under gastro-intestinal conditions. When the effect of gastro-225 
intestinal digestion in coffee and cardoon was studied, chlorogenic acids were proved to be quite 226 
stable (Juániz et al., 2017; Monente et al., 2015). Similarly, Tagliazucchi et al. (2010) and Bouayed 227 
et al. (2012) found that caffeic and coumaric acids were quite stable during in vitro gastro-intestinal 228 
digestion. On the other hand, Bouayed et al. (2012) observed a bioaccessibility of 31.6%-56.5% of 229 
hydroxycinnamic acids in selected apple varieties following in vitro gastro-intestinal digestion.  230 
Hydroxycinnamic acid-aspartate derivatives were the most bioaccessible hydroxycinnamic acids in 231 
the tested dark chocolates (Table 2). Ferulic acid (the most abundant hydroxycinnamic acid in dark 232 
chocolates) was detected in lower concentration in the intestinal environment respect to 233 
hydroxycinnamic acid-aspartate derivatives (Table 2). Coumaric acid was the only 234 
hydroxycinnamic acid recovered in the intestinal media at higher concentrations than its initial 235 
content in the samples. Coumaric acid and in general simple hydroxycinnamic acids are known to 236 
be strongly bound to fibers, such as cellulose, hemicellulose, lignin and pectin (Juaniz et al., 2016 237 
and 2017). However, Blancas-Benitez et al. (2015) found that hydroxycinnamic and 238 
hydroxybenzoic acids were efficiently released from mango dietary fiber during in vitro gastro-239 
intestinal digestion. Indeed, a loss of an OH-group in the phenolic ring of di-hydroxycinnamic acid 240 
isomers resulting in the formation of coumaric acid could be hypothesized, as already suggested by 241 
Juaniz et al. (2017). 242 
In addition, some isomerization reactions took place during in vitro gastro-intestinal digestion. 243 
Isomerization from 5-caffeoylquinic acid to 3-caffeoylquinic acid and 4-caffeoylquinic acid is 244 
highly pH-dependent and may occur during the intestinal step of the digestion process (alkaline pH) 245 
(Bermúdez-Soto, Tomás-Barberán, & García-Conesa, 2007; Juaniz et al., 2017). This may explain 246 
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the appearance of 4-caffeoylquinic acid in all the dark chocolates after in vitro gastro-intestinal 247 
digestion (Table 7). Similarly, other isomerization reactions might take place among galloylquinic 248 
acid isomers as observed in GTDC subjected to in vitro digestion (Table 5). 249 
Flavan-3-ols were the dominant class of phenolic compounds in the tested dark chocolates. 250 
However, due to their low bioaccessibility, hydroxycinnamic acids dominated the phenolic profile 251 
in in vitro digested chocolates, with the only exception of GTDC (Figure 2A and Table 1). While 252 
the monomeric flavan-3-ols appeared to be in some way bioaccessible, the recovered amount of 253 
procyanidins was extremely low and most of them were not found in the intestinal environment. 254 
(Epi)gallocatechin isomers were only detected after in vitro digestion of GTDC probably because 255 
they were present in higher concentration in GTDC respect to the other dark chocolate samples. The 256 
high instability of catechins and procyanidins had been reported earlier (Bouayed et al. 2012). In a 257 
previous study, procyanidin B2 was almost completely degraded into the monomeric epicatechin 258 
during gastric digestion (Kahle et al., 2011). The degradation of procyanidin B2, epicatechin and 259 
catechin into unknown degradation products in artificial intestinal conditions was also observed 260 
(Kahle et al., 2011; Zhu et al., 2002; Bouayed et al. 2012). In another study, epigallocatechin and 261 
epigallocatechin gallate were found to be sensitive to gastro-intestinal digestion with less than 10% 262 
recovery after in vitro digestion of green tea (Green, Murphy, Schulz, Watkins, & Ferruzzi, 2007). 263 
Some new compounds appearing in the intestinal environment may be indicative of catechin 264 
monomers degradation (Table 7). For example, trihydroxybenzene may be originated from the B-265 
ring of (epi)gallocatechin and epigallocatechin gallate. Indeed, after in vitro digestion of GTDC two 266 
new compounds were detected and identified as (epi)gallocatechin homodimers (theasinensin 267 
isomer and P2 analogue) (Neilson et al., 2007). Finally, the highest bioaccessibility of 268 
(epi)gallocatechin isomers and the higher content of gallic acid observed after digestion of GTDC, 269 
respect to the contents found in the chemical extract, could be explained as a consequence of 270 
hydrolysis of epigallocatechin gallate. 271 
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 272 
3.2 Effect of in vitro digestion on antioxidant activities 273 
In order to study how the antioxidant activity of the dark chocolate samples was modified 274 
throughout the digestive process, antioxidant activity was determined by FRAP and ABTS assays at 275 
each stage of the in vitro gastro-intestinal digestion and in the chemical extracts (Figure 3A and B). 276 
The GTDC chemical extract was the sample with the highest activity for both the assays (15.4 ± 1.4 277 
mmol trolox/100 g chocolate in ABTS and 15.4 ± 0.8 mmol trolox/100 g chocolate in FRAP). In 278 
general, it was observed that the two different assays gave similar trends for the distinct tested 279 
samples during the gastro-intestinal digestion. For all the tested samples, the antioxidant activity 280 
after the salivary phase was significantly lower than the antioxidant activity of the chemical 281 
extracts, in accordance with the low total phenolic content extracted after this step. Antioxidant 282 
activity increased after the gastric step of the digestion and further rose after the intestinal step. The 283 
91.5%, 74.0% and 80.1% of DC, GTDC and TDC antioxidant activities, respectively, was observed 284 
after intestinal digestion respect to the chemical extracts with the ABTS assay. The FRAP assay 285 
recovered lower antioxidant activity than those observed with the ABTS assay and equal to 37.6%, 286 
35.1% and 38.0% of DC, GTDC and TDC, respectively. Beside phenolic compounds, dark 287 
chocolate also contains other well-known antioxidants such as Maillard reaction products that can 288 
be formed during chocolate high temperature processes such as drying, roasting and conching 289 
(Quiroz-Reyes, & Fogliano, 2018). Differences between FRAP and ABTS values could be 290 
explained by considering that Maillard reaction products show a high chain-breaking activity 291 
despite their low reducing potential (Di Mattia, Sacchetti, Mastrocola, & Serafini, 2017). At the end 292 
of the gastro-intestinal digestion, GTDC displayed the highest amount of antioxidant activity in 293 
both the assays (11.4 ± 0.1 mmol trolox/100 g chocolate in ABTS and 5.4 ± 0.5 mmol trolox/100 g 294 
chocolate in FRAP). 295 
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These results are consistent with previous studies, where an increase in antioxidant activity was 296 
observed during digestion of grapes (Tagliazucchi et al., 2010), fruits (Tagliazucchi et al., 2012) 297 
and fruit extracts (Pavan, Sancho, & Pastore, 2014). However, other authors reported a large 298 
decrease in antioxidant activity after digestion of different foods (Garbetta et al., 2018; Lingua et 299 
al., 2018; Wang, Amigo-Benavent, Mateos, Bravo, & Sarriá, 2017). Multiple factors such as assay 300 
conditions, solubility and matrix effect may affect the antioxidant activity of foods and phenolic 301 
compounds during in vitro digestion. In any case, the antioxidant potential of dietary phenolic 302 
compounds in the intestinal tract, independently from their bioavailability, could offer protection by 303 
scavenging reactive oxygen species and reducing the oxidative stress at the intestinal cells level 304 
(Lingua et al., 2018 Tagliazucchi et al., 2010). 305 
 306 
3.3 Anti-proliferative activity of in vitro digested dark chocolate and dark chocolate enriched with 307 
Sakura green tea or turmeric powder phenolic-rich fractions on human colon adenocarcinoma 308 
cell lines  309 
The anti-proliferative activity of DC, GTDC and TDC phenolic-rich fractions extracted at the end 310 
of the in vitro gastro-intestinal digestion on the growth of human colon adenocarcinoma Caco-2 and 311 
SW-480 cells was investigated. Caco-2 and SW480 cells were incubated with different 312 
concentrations of phenolic-rich extracts ranging from 7 to 170 μmol/100 g of chocolate for 24 h. As 313 
shown in Figure 4, the inhibition was similar between DC and GTDC phenolic-rich fractions 314 
against Caco-2 cells. This result was not surprising, considering the similar phenolic profile of the 315 
two dark chocolates after in vitro gastro-intestinal digestion. However, when TDC phenolic-rich 316 
fraction was tested against Caco-2 cell line, a significantly lower IC50 value (which means a higher 317 
anti-proliferative activity) was found in comparison with the other two tested dark chocolates. All 318 
of the samples showed a higher anti-proliferative activity against SW480 respect to Caco-2. 319 
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According to the literature, there are no reports regarding the anti-proliferative activity of dark 320 
chocolate after in vitro digestion. 321 
Previous in vitro studies have shown anti-proliferative properties of procyanidin and procyanidin-322 
enriched extract isolated from cocoa powder in colon cancer Caco-2 cells (Carnesecchi et al., 2002; 323 
Martin and Ramos, 2017). However, 24 h treatment of Caco-2 and SW480 with catechin, 324 
epicatechin or procyanidin B2 did not affect cell growth, suggesting that other compounds rather 325 
than flavan-3-ols can be responsible for the observed anti-proliferative effect of phenolic-rich 326 
fractions extracted at the end of the in vitro gastro-intestinal digestion (Ramos, Rodríguez-Ramiro, 327 
Martín, Goya, & Bravo, 2011). The highest effect of TDC phenolic-rich fraction against Caco-2 cell 328 
line can be ascribed to the anti-proliferative activity of curcuminoids or a synergistic effect between 329 
curcuminoids and other phenolic compounds (Iwuchukwu, Tallarida, & Nagar, 2011). 330 
 331 
3.4. In vitro metabolism of digested dark chocolate phenolic-rich fraction in cell cultures 332 
In order to verify the cell metabolism of dark chocolate phenolic compounds, Caco-2 and SW480 333 
media were analysed by LC-MS ion trap after incubation (24 h) with in vitro digested dark 334 
chocolate (at concentration corresponding to IC50). Different metabolic reactions, including 335 
(de)hydroxylation, (de)hydrogenation, and conjugation with methyl, glucuronide, sulphate, and 336 
glutathione moieties were monitored. Some parent compounds and newly formed metabolites were 337 
detected in both cell types and reported in Table 8.  338 
In addition to the parent compounds catechin and epicatechin, two newly formed metabolites were 339 
tentatively identified. Methyl-(epi)catechin was found in the cell media of both the cell lines 340 
whereas dimethyl-(epi)catechin was found only in Caco-2 medium. Previous studies identified 341 
methyl-epicatechin and sulphate-epicatechin as the main metabolites in Caco-2 experiments with a 342 
prevalence of methylation (Aragonès et al., 2017; Sanchez-Bridge et al., 2015). The lack of 343 
identification of sulphate metabolites of (epi)catechin could be due to their low concentration in the 344 
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media (i.e. they could be formed but were below the limit of detection) or to the inhibition of the 345 
specific enzymes as a consequence of the presence of other phenolic compounds. Sanchez-Bridge et 346 
al. (2015) showed that the co-administration of epicatechin with flavonols, flavones and isoflavones 347 
reduced the metabolism of epicatechin (especially sulphation) in Caco-2. Despite the appearance in 348 
vivo of glucuronidated epicatechin metabolites, we did not find these substituted metabolites under 349 
our experimental conditions. Previous studies suggested the absence of specific uridine 5’-350 
diphospho-glucuronosyl-transferase isoforms able to form glucuronic acid conjugate of  epicatechin 351 
in Caco-2 cells (Actis-Goretta et al., 2013; Sanchez-Bridge et al., 2015).  352 
The main hydroxycinnamic acid derivatives found after in vitro gastro-intestinal digestion of dark 353 
chocolate were the conjugated forms with amino acids (such as aspartate and tyrosine, Table 2). 354 
With the exception of trace amounts of feruloyl-aspartate (found in the media of both cell lines), we 355 
were not able to identify these compounds after incubation with the two cell lines. Diversely, we 356 
found ferulic and coumaric acids in the media of both cell lines and caffeic acid only after 357 
incubation with SW480 cells. A sulphated form of coumaric acid and dihydro-ferulic acid were 358 
tentatively identified as newly formed metabolites in the cell culture media after incubation with 359 
SW480 and Caco-2, respectively. The concentration of coumaric acid increased from 5.10 ± 0.12 360 
after in vitro digestion to 86.14 ± 3.19 and 96.80 ± 4.96 μmol/100 g of chocolate after 24 h of 361 
incubation with Caco-2 and SW480, respectively (Table 2 and Table 8). The increased amount of 362 
coumaric acid may derive from hydroxylation of cinnamic acid (which was present in the dark 363 
chocolate after in vitro gastro-intestinal digestion but not in the cell culture media, data not shown), 364 
dehydroxylation of caffeic acid or dehydrogenation of dihydro-coumaric acid, as already suggested 365 
by Poquet, Clifford, & Williamson (2008) for dihydro-ferulic acid. Alternatively, a hydrolysis of 366 
coumaroyl-aspartate and/or coumaroyl-tyrosine, catalysed by membrane-bound carboxypeptidases, 367 
may be hypothesized. Indeed, coumaric acid has been found particularly stable when incubated with 368 
Caco-2 or rat hepatic cells (Kahle et al., 2011; Kern et al., 2003). After 24 h of incubation with 369 
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Caco-2 an increased amount of ferulic acid respect to the concentration found at the end of the 370 
digestion was detected (Table 2 and Table 8). Methylation of caffeic acid by catechol-O-371 
methyltransferase may account for the increase in ferulic acid concentration (Kern et al., 2003). 372 
This conclusion is supported also by the evidence of the disappearance of caffeic acid from the 373 
medium. Indeed, methylation of di-hydro-caffeic acid may account for the appearance of di-hydro-374 
ferulic acid in the medium, as already suggested in Caco-2 cells by Poquet et al. (2008).  375 
The same conclusions can not be drawn for SW480. In the medium of this cell line we found some 376 
residual caffeic acid and the amount of ferulic acid did not increase during incubation (Table 2 and 377 
Table 8). Indeed, we did not identify di-hydro-ferulic acid in the medium of SW480. This evidence 378 
suggested that caffeic and di-hydro-caffeic acid were not substrates for the catechol-O-379 
methyltransferase in SW480, despite its presence as indicated by the appearance of methylated 380 
(epi)catechin as reported above. Therefore, hydroxycinnamic acids metabolism under our 381 
experimental conditions resulted in the accumulation of coumaric and ferulic acids in cell media 382 
with only minor phase II metabolism. Figure 5 reported the hypothetical pathways of 383 
hydroxycinnamic acids metabolism leading to the accumulation of coumaric and ferulic acids. 384 
Quercetin-hexoside and quercetin-pentoside were tentatively identified after 24 h of incubation with 385 
SW480 cell line, despite their low concentration in the sample after in vitro gastro-intestinal 386 
digestion. This is indicative of their relative stability in cell culture medium as already suggested by 387 
Xiao, & Högger (2015). Instead, quercetin-hexoside was not identified after 24 h of incubation with 388 
Caco-2. The aglycone quercetin, which was not present in dark chocolate after in vitro gastro-389 
intestinal digestion, appeared after incubation with Caco-2, suggesting that this cell line was able to 390 
de-glycosylate quercetin-hexoside releasing the corresponding aglycone. De-glycosylation of 391 
flavonoid glycosides can be catalysed by the action of membrane-bound lactase phloridzin 392 
hydrolase and/or cytosolic β-glucosidase (Németh et al., 2003). Some previous studies failed to 393 
detect de-glycosylation of quercetin-glucoside by using Caco-2 cells (del Mar Contreras, Borrás-394 
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Linares, Herranz-López, Micol, & Segura-Carretero, 2015; Walgren, Walle, & Walle, 1998). 395 
However, Caco-2 cells express both lactase phloridzin hydrolase and cytosolic β-glucosidase 396 
(Németh et al., 2003). This discrepancy can be due to the shorter incubation time in the previous 397 
studies (1-2 h vs 24 h in our study). Quercetin was not identified in SW480 cell culture medium, 398 
suggesting that this cell line was not able to hydrolyse quercetin-hexoside. 399 
Finally, one methylated derivative of ellagic acid was tentatively identified only in the SW480 cell 400 
medium. 401 
 402 
4. Conclusions 403 
Bioactivity of phenolic compounds is primarily conditioned by their bioaccessibility in the gastro-404 
intestinal tract, and secondly by their cellular uptake and internal transformation. The present study 405 
determined the amounts of bioaccessible dark chocolate phenolic compounds after gastro-intestinal 406 
digestion. We have demonstrated that gastro-intestinal digestion modified the phenolic profile in the 407 
samples from a qualitative and quantitative point of view.  408 
We have also demonstrated that Caco-2 and SW480 cell lines showed metabolic activity resulting 409 
in a partial modification of dark chocolate phenolic compounds leading to the accumulation of 410 
coumaric and ferulic acids in the cell media. The observed anti-proliferative activity could be 411 
related to the accumulation of these simple hydroxycinnamic acids. The presence of ferulic acid and 412 
quercetin in Caco-2 cell medium at higher concentration than in SW480 cell medium or the 413 
presence of caffeic acid only in SW480 cell medium may suggest the intrinsic differences between 414 
the two cell lines and the metabolic mechanisms involved. Further studies are necessary in order to 415 
confirm the proposed pathways of metabolism of hydroxycinnamic acids during incubation with 416 
cell lines and their potential anti-proliferative activity. 417 
The addition of green tea leaves or turmeric powder in dark chocolate recipe lead to a modification 418 
of dark chocolate healthy properties. Functionalization with green tea leaves resulted in a higher 419 
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amount of flavan-3-ols and flavonols after in vitro digestion than dark chocolate, achieving a more 420 
efficient antioxidant activity. Similarly, the addition of turmeric powder may lead to an increased 421 
anti-proliferative activity against adenocarcinoma cell lines respect to DC and GTDC. 422 
In this way, the potential healthy effect of dark chocolate consumption could be maximized, 423 
reducing the amount of energy and calories introduced with chocolate itself and resulting in a lower 424 
intake to achieve the same biological effects. 425 
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Figure captions 
Figure 1. Changes in total phenolic content during in vitro gastro-intestinal digestion. Total 
phenolic content was determined with the Folin-Ciocalteau assay and expressed as μmol of gallic 
acid equivalents/100 g of chocolate. Light grey columns represent the changes detected during in 
vitro digestion of dark chocolate. Grey columns represent the changes detected during in vitro 
digestion of dark chocolate enriched with Sakura green tea leaves. Dark grey columns represent the 
changes detected during in vitro digestion of dark chocolate enriched with turmeric powder. Results 
are expressed as mean ± standard deviation. Different letters refer to statistically significant 
differences (P<0.05) in total phenolic compounds content among samples. 
Figure 2. Bioaccessibility of individual phenolic compounds identified and quantified by LC-
ESI-QTOF MS/MS grouped by classes. (A) Flavan-3-ols; (B) hydroxycinnamic acids; (C) 
flavonols; (D) other phenolics; (E) flavones; (F) ellagitannins; (G) hydroxybenzoic acids; (H) sum 
of the different classes. DC identify dark chocolate; GTDC identify dark chocolate enriched with 
Sakura green tea leaves; TDC identify dark chocolate enriched with turmeric powder. Black 
columns represent the amount of the individual classes found in the chemical extract whereas grey 
columns the amount at the end of the digestion. 
Figure 3. Changes in antioxidant activity during in vitro gastro-intestinal digestion. 
Antioxidant capacity (expressed as mmol of trolox equivalent/100 g of chocolate), measured by 
ABTS (A) and FRAP (B) assays. Light grey columns represent the changes detected during in vitro 
digestion of dark chocolate. Grey columns represent the changes detected during in vitro digestion 
of dark chocolate enriched with Sakura green tea leaves. Dark grey columns represent the changes 
detected during in vitro digestion of dark chocolate enriched with turmeric powder digestion. 
Results are expressed as mean ± standard deviation. Values in the same graph with different 
lowercase letters are significantly different (P < 0.05). 
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Figure 4. Anti-proliferative activity of phenolic-rich fractions extracted at the end of the in 
vitro digestion. DC identify dark chocolate; GTDC identify dark chocolate enriched with Sakura 
green tea leaves; TDC identify dark chocolate enriched with turmeric powder. IC50 is defined as the 
concentration of phenolic compounds required to inhibit 50% of cell proliferation. The amount of 
phenolic compounds was determined by LC-ESI-QTOF MS/MS analysis as described in material 
and methods. Dark grey columns represent the IC50 versus Caco-2 cells. Grey columns represent the 
IC50 versus SW480 cells. Values in with different lowercase letters are significantly different (P < 
0.05). 
Figure 5. Proposed pathways for hydroxycinnamic acids metabolism after incubation with 
Caco-2 and SW480 cell lines of dark chocolate phenolic-rich fractions extracted at the end of 
the in vitro digestion. COMT: catechol-O-methyl transferase; CPase: carboxypeptidase; RA: 
reduction; DHY: de-hydroxylation; HYD: hydroxylation; SULT: sulfotransferase. Compounds in 
dark grey boxes were detected both in in vitro digested samples and after incubation with cells; 
compounds in light grey boxes were detected only in in vitro digested samples; compounds in white 
boxes were detected only after incubation with cells. The unbroken arrows indicate previously 
demonstrated pathways whereas dotted arrows indicate pathways hypothesized in this study. Steps 
not found in SW480 are indicated. Please note that caffeic acid was found only after incubation 
with SW480 whereas di-hydro-ferulic acid was found only after incubation with Caco-2. 
 
 





Table 1. Quantitative results (μmol/100 g of chocolate) for flavan-3-ols identified in dark chocolate after 
chemical extraction and after gastro-intestinal digestion. Values represent means ± standard deviation of 
triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction 
After 
digestion 
Chemical 
extraction After digestion 
        Flavan-3-ols 
Catechin 228.28 ± 6.86a 42.00 ± 6.65b 240.07 ± 18.28a 47.18 ± 2.12b 245.28 ± 3.97a 40.21 ± 5.40b 
Epicatechin 701.00 ± 26.48a 124.75 ± 7.79b 1047.21 ± 40.17c 175.59 ± 6.55d 753.21 ± 27.86a 126.66 ± 8.23b 
Gallocatechin 1.48 ± 0.03a n.d. 7.21 ± 0.48b 6.58 ± 0.20b < LOQ n.d. 
Epigallocatechin 54.93 ± 0.34a n.d. 102.62 ± 6.00b 53.64 ± 0.78a 52.10 ± 2.76a n.d. 
(Epi)catechin-O-
sulphate isomer 7.10 ± 0.45
a
 4.21 ± 0.23b 5.97 ± 0.69a 3.75 ± 0.13b 10.59 ± 1.07c 4.81 ± 0.11d 
(Epi)catechin-O-
sulphate isomer 24.66 ± 1.21
a
 14.13 ± 1.01b 24.69 ± 0.41a 14.65 ± 0.93b,d 35.28 ± 2.86c 16.10 ± 0.61d 
(Epi)catechin-3-O-
trihydroxybenzene 16.97 ± 1.72
a,d
 1.11 ± 0.01b 16.07 ± 0.34a 1.68 ± 0.06c 20.48 ± 1.93d 1.08 ± 0.01b 
(Epi)catechin-3-O- 
trihydroxybenzene 12.45 ± 0.21
a
 1.01 ± 0.05b 15.79 ± 0.90c 1.33 ± 0.02d 16.69 ± 1.45c 0.65 ± 0.02e 
(Epi)catechin-7-O-
trihydroxybenzene 8.97 ± 0.52
a
 0.82 ± 0.02b 13.21 ± 1.93c 1.10 ± 0.08b 11.69 ± 0.48c 0.40 ± 0.01d 
(Epi)catechin-C-
pentoside isomer 1.45 ± 0.17
a
 0.74 ± 0.01b 1.03 ± 0.24a 0.86 ± 0.01b 2.86 ± 0.38c 0.90 ± 0.03b 
Catechin-3-O-
gallate* n.d. n.d. < LOQ < LOQ n.d. n.d. 
Epicatechin-3-O-
gallate * n.d. n.d. 31.45 ± 0.45
a
 1.16 ± 0.11b n.d. n.d. 
(Epi)catechin-3-O-
hexoside isomer 43.59 ± 0.69
a
 10.95 ± 0.52b 33.72 ± 4.62c 13.16 ± 0.62d 12.10 ± 1.79d 7.13 ± 0.42e 
(Epi)catechin-C-
hexoside isomer 6.59 ± 0.14
a
 4.90 ± 0.19b 5.59 ± 0.34c 6.17 ± 0.27a,c 4.55 ± 0.66b 6.74 ± 0.34a 
(Epi)catechin-7-O-
hexoside 14.17 ± 1.00
a
 3.64 ± 0.16b 14.69 ± 1.03a 4.30 ± 0.17c 18.07 ± 0.10d 1.41 ± 0.02e 
(Epi)catechin-C-
hexoside isomer 14.10 ± 0.72
a
 8.11 ± 0.54b 12.00 ± 2.76a 9.67 ± 0.37c 12.83 ± 0.01a 9.02 ± 0.40b,c 
(Epi)catechin-3-O-
hexoside isomer 4.69 ± 0.72
a
 2.18 ± 0.10b 6.24 ± 0.76a 3.10 ± 0.16c 5.10 ± 0.28a 1.81 ± 0.01d 
Epigallocatechin-3-
O-gallate * n.d. n.d 115.66 ± 7.45
a
 3.20 ± 0.34b n.d n.d. 
Gallocatechin-3-O-
hexoside 0.31 ± 0.03
a
 1.41 ± 0.02b 0.21 ± 0.01a 1.52 ± 0.02b 0.52 ± 0.03c 1.49 ± 0.02b 
Epigallocatechin-3-
O-hexoside 0.31 ± 0.03
a
 1.27 ± 0.01b 0.24 ± 0.01a 1.80 ± 0.05c 0.59 ± 0.03d 1.41 ± 0.01e 
Procyanidin dimer 
A type 3.79 ± 0.21
a
 n.d. 4.52 ± 0.28a n.d. 4.17 ± 0.24a n.d. 
Procyanidin dimer 
B type isomer 29.83 ± 2.90
a
 2.09 ± 0.23b 28.93 ± 1.17a 2.08 ± 0.05b 36.52 ± 5.10a 1.48 ± 0.11c 
Procyanidin dimer 
B type isomer 10.52 ± 0.76
a,c
 1.12 ± 0.24b 9.28 ± 0.14a < LOQ 12.48 ± 0.66c 1.04 ± 0.13b 
Procyanidin dimer 
B type isomer 128.38 ± 11.86
a
 n.d. 180.86 ± 18.76b 2.29 ± 0.15c 121.10 ± 0.14a n.d. 
Procyanidin dimer 
B type isomer 117.52 ± 6.83
a
 19.56 ± 0.54b 155.14 ± 3.97c 24.26 ± 1.03d 131.90 ± 9.52a 23.60 ± 1.66d 
Procyanidin dimer 
B type isomer 18.34 ± 1.03
a
 n.d. 22.97 ± 2.21b n.d. 23.90 ± 2.55b < LOQ 
Procyanidin dimer 
B type isomer 35.07 ± 0.45
a
 n.d. 42.59 ± 1.21b 1.92 ± 0.11c 45.24 ± 3.07b < LOQ 
(Epi)catechin-
(Epi)gallocatechin * n.d. n.d. 0.41 ± 0.03a  n.d. n.d. n.d. 
(Epi)catechin-3-O-
dihexoside isomer 2.28 ± 0.03
a
 n.d. 2.52 ± 0.03a < LOQ 1.52 ± 0.03b < LOQ 
(Epi)catechin-3-O-
dihexoside isomer 5.69 ± 0.07
a
 n.d. 3.59 ± 1.76b n.d. 4.62 ± 0.10b n.d. 
(Epi)catechin-3-O-
gallate-7-O- 
glucuronide isomer 
1.14 ± 0.03a n.d. 0.62 ± 0.03b < LOQ 0.83 ± 0.10b n.d. 
(Epi)catechin-3-O- 
gallate-7-O-
glucuronide isomer 
1.07 ± 0.07a n.d. 0.48 ± 0.03b < LOQ 0.79 ± 0.07b n.d. 
(Epi)catechin 
derivative isomer 4.00 ± 0.14
a,b
 < LOQ 3.21 ± 0.34a 0.37 ± 0.01 4.48 ± 0.48b < LOQ 
(Epi)catechin 
derivative isomer 3.52 ± 0.14
a
 < LOQ 3.66 ± 0.14a 0.28 ± 0.02 2.66 ± 0.17b n.d. 
Procyanidin dimer 
A type pentoside 
isomer 
4.90 ± 0.03a n.d. 4.45 ± 0.83a n.d. 5.79 ± 0.14b < LOQ 
Procyanidin dimer 
A type pentoside 
isomer 
3.76 ± 0.03a n.d. 4.03 ± 0.28a n.d. 3.59 ± 0.14a < LOQ 
Procyanidin dimer 
A type pentoside 
isomer 
6.03 ± 0.10a n.d. 7.72 ± 0.72b n.d. 6.28 ± 0.38a < LOQ 
Procyanidin dimer 
A type pentoside 
isomer 
5.07 ± 0.38a n.d. 9.45 ± 0.38b n.d. 4.14 ± 0.21a < LOQ 
Procyanidin dimer 
A type hexoside 
isomer 
5.10 ± 0.21a n.d. 5.24 ± 0.79a,b n.d. 6.59 ± 0.24b < LOQ 
Procyanidin dimer 
A type hexoside 
isomer 
3.48 ± 0.10a 0.42 ± 0.01b 4.28 ± 0.38c 0.45 ± 0.01b 5.45 ± 0.17d n.d. 
Procyanidin dimer 
A type hexoside 
isomer 
7.10 ± 0.31a n.d. 10.66 ± 1.28b < LOQ 8.03 ± 0.17a < LOQ 
Procyanidin dimer 
A type hexoside 
isomer 
5.07 ± 0.10a n.d. 8.90 ± 0.52b < LOQ 7.10 ± 0.10c < LOQ 
Procyanidin dimer 
B type hexoside 
isomer 
2.76 ± 0.14a 1.78 ± 0.08b 3.07 ± 0.24a 1.93 ± 0.03b 3.52 ± 0.34a 1.68 ± 0.08b 
Procyanidin dimer 
B type hexoside 
isomer 
3.59 ± 0.07a 0.92 ± 0.01b 3.66 ± 0.14a 1.22 ± 0.07c 4.21 ± 0.14d 1.03 ± 0.07a 
Procyanidin dimer 
B type hexoside 
isomer 
1.76 ± 0.28a 1.08 ± 0.02b 1.90 ± 0.10a 1.29 ± 0.02b 1.86 ± 0.14a 1.21 ± 0.02b 
Procyanidin dimer 
B type derivative 6.41 ± 0.10
a
 2.88 ± 0.09b 6.48 ± 1.62a 2.75 ± 0.15b 7.83 ± 0.45a 1.75 ± 0.11c 
Procyanidin trimer 
A type 2.41 ± 0.17
a
 n.d. 2.31 ± 0.14a n.d. 3.34 ± 0.14b n.d. 
Procyanidin trimer 
B type isomer 3.21 ± 0.17
a
 n.d. 3.17 ± 0.10a < LOQ 3.83 ± 0.38a n.d. 
Procyanidin trimer 
B type isomer 14.83 ± 1.07
a
 0.34 ± 0.02b 24.59 ± 1.76c 0.73 ± 0.01d 17.10 ± 1.41a n.d. 
Procyanidin trimer 
B type isomer 11.07 ± 0.24
a
 0.20 ± 0.01b 14.48 ± 0.86b < LOQ 12.59 ± 0.38b n.d. 
Procyanidin trimer 
B type isomer 38.00 ± 1.55
a
 n.d. 52.28 ± 3.10b n.d. 40.00 ± 2.21a < LOQ 
Procyanidin trimer 
B type isomer 30.69 ± 0.59
a
 0.46 ± 0.01b 60.31 ± 4.62c n.d. 33.24 ± 0.17a n.d. 
Procyanidin trimer 
B type isomer 12.41 ± 0.66
a
 n.d. 12.66 ± 0.62a n.d. 12.07 ± 0.76a n.d. 
Procyanidin trimer 
B type isomer 7.07 ± 0.28
a
 n.d. 7.41 ± 0.24a n.d. 10.03 ± 0.52b n.d. 
Procyanidin trimer 
B type isomer 3.83 ± 0.10
a
 n.d. 5.79 ± 0.28b n.d. 4.76 ± 0.07c n.d. 
Procyanidin trimer 
A type hexoside 
isomer 
2.41 ± 0.21a n.d. 3.41 ± 0.10b n.d. 2.90 ± 0.24a n.d. 
Procyanidin trimer 
A type hexoside 
isomer 
1.86 ± 0.07a n.d. 3.34 ± 0.10b n.d. 2.41 ± 0.14c n.d. 
Procyanidin 
tetramer A type 
isomer 
4.97 ± 0.03a n.d. 4.76 ± 0.24a < LOQ 4.90 ± 0.28a < LOQ 
Procyanidin 
tetramer A type 
isomer 
6.97 ± 0.45a n.d. 12.69 ± 1.97b n.d. 7.03 ± 0.55a < LOQ 
Procyanidin 
tetramer A type 
isomer 
6.97 ± 0.10a n.d. 13.93 ± 2.83b < LOQ 9.76 ± 0.28c < LOQ 
Procyanidin 
tetramer A type 
isomer 
2.72 ± 0.24a,b n.d. 3.83 ± 1.00a < LOQ 2.28 ± 0.21b n.d. 
Procyanidin 
tetramer B type 
isomer 
1.28 ± 0.03a n.d. 6.28 ± 0.17b n.d. 1.28 ± 0.17a n.d. 
Procyanidin 
tetramer B type 
isomer 
4.62 ± 0.14a n.d. 6.24 ± 0.76b n.d. 6.38 ± 0.17b n.d. 
Procyanidin 
tetramer B type 
isomer 
3.21 ± 0.10a n.d. 6.28 ± 0.24b n.d. 5.90 ± 0.55b < LOQ 
Procyanidin 
tetramer B type 
isomer 
4.10 ± 0.28a n.d. 8.90 ± 0.10b n.d. 5.69 ± 0.03c n.d. 
Procyanidin 
pentamer B type 
isomer 
2.07 ± 0.07a n.d. 1.90 ± 0.14a n.d. 2.31 ± 0.02a n.d. 
Procyanidin 
pentamer B type 
isomer 
2.83 ± 0.14a n.d. 5.34 ± 0.48b n.d. 3.41 ± 0.01c n.d. 
Procyanidin 
pentamer B type 
isomer 
4.03 ± 0.28a n.d. 11.97 ± 0.97b n.d. 6.03 ± 0.14c n.d. 
Procyanidin 
hexamer A type < LOQ n.d. < LOQ n.d. < LOQ n.d. 
Procyanidin 
hexamer B type 
isomer 
1.07 ± 0.03a n.d. 3.38 ± 0.07b n.d. 1.28 ± 0.07a n.d. 
Procyanidin 
hexamer B type 
isomer 
1.50 ± 0.14a n.d. 4.66 ± 0.14b n.d. 1.00 ± 0.03c n.d. 
Procyanidin 
hexamer B type 
isomer 
0.76 ± 0.07a n.d. 6.38 ± 0.69b n.d. 1.59 ± 0.14c n.d. 
< LOQ means the compound was detected but it was below the limit of quantification; n.d. means not detected 
* mean the compounds were detected only in green tea dark chocolate.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Flavan-3-ols were quantified as epicatechin equivalent. 
Data from chemical extraction were from Martini et al. (2018). 
Table 2. Quantitative results (μmol/100 g of chocolate) for hydroxycinnamic acids identified in dark 
chocolate after chemical extraction and after gastro-intestinal digestion. Values represent means ± standard 
deviation of triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
        Hydroxycinnamic acids 
Coumaric acid 2.07 ± 0.06a 5.10 ± 0.12b 2.26 ± 0.30a 5.02 ± 0.20b 3.35 ± 0.06c 5.34 ± 0.42b 
Di-hydro-coumaric 
acid 49.57 ± 0.85
a
 31.29 ± 2.09b 27.87 ± 0.49c 17.06 ± 0.94d 68.17 ± 2.50e 38.31 ± 2.10b 
Di-
hydroxycinnamic 
acid isomer 
5.61 ± 0.06a 4.96 ± 0.27b 6.95 ± 0.12c,e 7.31 ± 0.32c 14.21 ± 0.18d 6.41 ± 0.31e 
Di-
hydroxycinnamic 
acid isomer 
2.93 ± 0.12a 1.05 ± 0.21b 2.20 ± 0.06c 1.15 ± 0.02b 3.48 ± 0.06d 1.05 ± 0.16b 
Caffeic acid 6.59 ± 0.06a 2.16 ± 0.06b 10.24 ± 0.12c 2.82 ± 0.14d 6.65 ± 0.12a 2.78 ± 0.18d 
Di-
hydroxycinnamic 
acid isomer 
2.93 ± 0.06a 1.35 ± 0.10b 2.07 ± 0.01c 1.13 ± 0.08b 3.66 ± 0.24d 1.82 ± 0.04c 
Di-
hydroxycinnamic 
acid isomer 
3.54 ± 0.06a 0.46 ± 0.01b 3.84 ± 0.18a 1.02 ± 0.02c 3.54 ± 0.18a 0.57 ± 0.01b 
Di-hydro-caffeic 
acid 11.46 ± 0.98
a
 1.79 ± 0.06b 1.46 ± 0.01c < LOQ 5.37 ± 0.24d 1.47 ± 0.05e 
Ferulic acid 315.62 ± 19.28a 27.89 ± 3.21b 299.43 ± 12.01a 16.92 ± 1.25c 285.05 ± 7.01a 17.37 ± 0.93c 
Coumaroyl 
aspartate 95.85 ± 1.40
a
 69.18 ± 2.65b 85.79 ± 0.30c 65.26 ± 3.42b 102.62 ± 1.04d 79.55 ± 1.22e 
Di-
hydroxycinnamic 
aspartate isomer 
52.38 ± 3.17a 22.70 ± 1.37b 41.83 ± 0.98c 21.47 ± 1.04b 42.20 ± 0.24c 25.11 ± 0.48b 
Di-
hydroxycinnamic 
aspartate isomer 
218.78 ± 17.62a 119.70 ± 8.28b 204.15 ± 1.52a 121.05 ± 11.06b 201.95 ± 3.54a 130.79 ± 3.69b 
Feruloyl aspartate 42.16 ± 0.31a 36.91 ± 2.09b 48.96 ± 0.36c 26.49 ± 1.25d 46.19 ± 2.11a,c 38.66 ± 1.36b 
Ferulic acid-4-O-
pentoside 2.06 ± 0.01
a
 1.24 ± 0.04b 2.47 ± 0.01c 1.92 ± 0.01a 2.42 ± 0.10c 1.27 ± 0.02b 
Di-deoxyclovamide 
(Coumaroyl-
DOPA) 
28.41 ± 1.28a 14.85 ± 1.02b 28.96 ± 0.12a 15.32 ± 1.06b 27.87 ± 1.46a 16.82 ± 1.07b 
3-Coumaroylquinic 
acid cis * n.d. n.d. 9.21 ± 0.10
a
 6.59 ± 0.66b n.d. n.d. 
3-Coumaroylquinic 
acid trans * n.d. n.d. 4.15 ± 0.10
a
 3.84 ± 0.40b n.d. n.d. 
4-Coumaroylquinic 
acid cis * n.d. n.d. 12.50 ± 0.61
a
 8.47 ± 0.66b n.d. n.d. 
4-Coumaroylquinic 
acid trans * 
 
n.d. n.d. 21.46 ± 0.55a 17.62 ± 1.41b n.d. n.d. 
Mono-
deoxyclovamide 
(Caffeoyl-DOPA / 
Coumaroyl-
tyrosine) isomer 
3.54 ± 0.01a 1.78 ± 0.11b 2.93 ± 0.24c 1.38 ± 0.20b 3.05 ± 0.01c 1.47 ± 0.03b 
Mono-
deoxyclovamide 
(Caffeoyl-DOPA / 
Coumaroyl-
17.87 ± 0.12a 9.06 ± 0.78b 13.72 ± 0.61c 9.16 ± 0.57b 12.87 ± 0.79c 9.12 ± 0.21b 
tyrosine) isomer 
5-Caffeoylquinic 
acid 1.40 ± 0.12
a
 0.76 ± 0.01b 3.96 ± 0.12c 3.44 ± 0.14d 1.52 ± 0.18a 0.81 ± 0.01b 
3-Caffeoylquinic 
acid 0.73 ± 0.12
a
 0.50 ± 0.01b 1.89 ± 0.12c 1.78 ± 0.07c 1.28 ± 0.06d 0.50 ± 0.01b 
Clovamide 
(caffeoyl-tyrosine) 
isomer 
11.04 ± 0.30a 3.16 ± 0.12b 8.66 ± 0.12c 3.34 ± 0.17b 7.20 ± 0.43d 2.63 ± 0.11e 
Clovamide 
(caffeoyl-tyrosine) 
isomer 
47.13 ± 3.29a 23.71 ± 0.93b 54.51 ± 2.20a 25.64 ± 1.28b 50.67 ± 0.06a 20.02 ± 1.23b 
< LOQ means the compound was detected but it was below the limit of quantification; n.d. means not detected 
* mean the compounds were detected only in green tea dark chocolate.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Hydroxycinnamic acids were quantified as coumaric acid or ferulic acid equivalent. 
Data from chemical extraction were from Martini et al. (2018). 
Table 3. Quantitative results (μmol/100 g of chocolate) for flavonols identified in dark chocolate after 
chemical extraction and after gastro-intestinal digestion. Values represent means ± standard deviation of 
triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
        Flavonols 
Quercetin 1.77 ± 0.02a n.d. 2.66 ± 0.05b < LOQ 2.25 ± 0.02c < LOQ 
Quercetin-3-O-
pentoside 5.43 ± 0.34
a
 0.15 ± 0.01b 4.59 ± 0.23c 0.29 ± 0.01b 6.80 ± 0.66d 0.20 ± 0.01b 
Kaempferol-7-O-
hexoside 0.23 ± 0.01
a
 n.d. 0.39 ± 0.02a n.d. 0.25 ± 0.02a n.d. 
Kaempferol-3-O-
galactoside 0.07 ± 0.01
a
 n.d. 0.46 ± 0.01b < LOQ < LOQ n.d. 
Kaempferol-3-O-
glucoside 0.08 ± 0.01
a
 < LOQ 0.61 ± 0.05b < LOQ < LOQ n.d. 
Quercetin-3-O-
rhamnoside 0.08 ± 0.01
a
 n.d. 0.82 ± 0.03b < LOQ < LOQ n.d. 
Dihydro-
kaempferol-7-O-
hexoside 
0.41 ± 0.02a n.d. 0.34 ± 0.02a n.d. 0.38 ± 0.02a n.d. 
Quercetin-3-O-
galactoside 0.80 ± 0.02
a
 0.10 ± 0.01b 2.74 ± 0.14c n.d. 4.00 ± 0.07d 0.09 ± 0.01b 
Quercetin-3-O-
glucoside 3.21 ± 0.03
a
 0.28 ± 0.01b 3.75 ± 0.11a 0.49 ± 0.03b 5.00 ± 0.44c 0.24 ± 0.01b 
Myricetin-3-O-
galattoside 0.49 ± 0.01
a
 n.d. 3.85 ± 0.07b 0.39 ± 0.01a < LOQ n.d. 
Myricetin-3-O-
glucoside 0.75 ± 0.02
a
 n.d. 3.02 ± 0.23b 0.52 ± 0.03a < LOQ n.d. 
Kaempferol-3-O-
rutinoside 0.43 ± 0.01
a
 < LOQ 1.07 ± 0.03b 0.41 ± 0.01a < LOQ n.d. 
Quercetin-3-O-
rutinoside * n.d. n.d. 6.89 ± 0.31
a
 1.19 ± 0.08b n.d. n.d. 
Myricetin-3-O-
rutinoside * n.d. n.d. 0.95 ± 0.02
a
 0.33 ± 0.03b n.d. n.d. 
Myricetin-3-O-(O-
galloyl) hexoside 0.18 ± 0.01a n.d. 1.02 ± 0.03b 0.11 ± 0.01a < LOQ n.d. 
Kaempferol-7-O-
rhamnoside-3-O-
rutinoside 
0.05 ± 0.01a n.d. 0.15 ± 0.02b 0.04 ± 0.01a < LOQ n.d. 
Quercetin-7-O-
rhamnoside-3-O-
rutinoside 
0.23 ± 0.01a n.d. 0.33 ± 0.03a 0.16 ± 0.01a < LOQ n.d. 
Kaempferol-7-O-
hexoside-3-O-
rutinoside isomer 
0.93 ± 0.01a n.d. 2.08 ± 0.03b 0.95 ± 0.04a < LOQ n.d. 
Kaempferol-7-O-
hexoside-3-O-
rutinoside isomer 
0.72 ± 0.01a n.d. 2.26 ± 0.02b 1.16 ± 0.06c < LOQ n.d. 
Quercetin-7-O-
hexoside-3-O-
rutinoside isomer 
1.84 ± 0.01a n.d. 3.67 ± 0.02b 1.62 ± 0.13a < LOQ n.d. 
Quercetin-7-O-
hexoside-3-O-
rutinoside isomer 
3.43 ± 0.21a n.d. 5.98 ± 0.43b 2.93 ± 0.16a < LOQ n.d. 
Myricetin-7-O-
hexoside-3-O-
rutinoside 
0.20 ± 0.01a n.d. 0.38 ± 0.03a 0.16 ± 0.01a < LOQ n.d. 
< LOQ means the compound was detected but it was below the limit of quantification; n.d. means not detected 
* mean the compounds were detected only in green tea dark chocolate.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Flavonols were quantified as quercetin-3-O-rutinoside equivalent. 
Data from chemical extraction were from Martini et al. (2018). 
 
Table 4. Quantitative results (μmol/100 g of chocolate) for flavones, ellagitannins, curcuminoids and other 
phenolics identified in dark chocolate after chemical extraction and after gastro-intestinal digestion. Values 
represent means ± standard deviation of triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
        Other phenolics  
Vanillin 8.64 ± 0.32a 2.24 ± 0.19b 2.97 ± 0.18c 2.10 ± 0.12b 3.03 ± 0.13c 1.51 ± 0.08d 
Phloretin-C-
hexoside isomer 0.25 ± 0.01
a
 < LOQ 0.26 ± 0.01a 0.07 ± 0.01b 1.03 ± 0.05c n.d. 
Eriodictyol-7-O-
hexoside 0.16 ± 0.02
a
 < LOQ 0.31 ± 0.02b 0.58 ± 0.01c 0.87 ± 0.05d n.d. 
Cinchonain isomer 6.24 ± 0.69a 0.66 ± 0.02b 3.90 ± 0.03c 0.87 ± 0.06b 7.21 ± 0.10a 0.73 ± 0.01b 
Cinchonain isomer 2.66 ± 0.21a n.d. 2.72 ± 0.07a n.d. 2.59 ± 0.07a n.d. 
Naringenin-C-
hexoside-7-O-
hexoside isomer 
0.38 ± 0.01a < LOQ 1.03 ± 0.03b 0.73 ± 0.01c < LOQ n.d. 
Eriodictyol-C-
hexoside-7-O-
hexoside isomer 
0.25 ± 0.01a n.d. 0.46 ± 0.02b 0.45 ± 0.01b < LOQ n.d. 
Flavones 
Apigenin-C-
hexoside isomer 0.16 ± 0.02
a
 < LOQ 0.69 ± 0.02b 0.19 ± 0.01a 0.31 ± 0.0a n.d. 
Apigenin-C-
hexoside-C-
pentoside isomer 
1.56 ± 0.02a 0.12 ± 0.01b 3.46 ± 0.11c 0.35 ± 0.02d 1.36 ± 0.05a 0.12 ± 0.01b 
Apigenin-C-
hexoside-2''-O-
rhamnoside isomer 
2.15 ± 0.52a n.d. 1.46 ± 0.21b 0.30 ± 0.01c 2.80 ± 0.70a n.d. 
Apigenin-6,8-di-C-
hexoside isomer 0.28 ± 0.02
a
 n.d. 0.77 ± 0.02b < LOQ 0.38 ± 0.02a 0.35 ± 0.03a 
Apigenin-6,8-di-C-
hexoside isomer 0.33 ± 0.02
a
 0.29 ± 0.01a 0.89 ± 0.01b 1.00 ± 0.05b 0.54 ± 0.02c n.d. 
Apigenin-C-
hexoside-2’'-O-
hexoside isomer 
0.41 ± 0.01a n.d. 0.77 ± 0.04b 0.40 ± 0.01a < LOQ n.d. 
Ellagitannins 
Ellagic acid 185.96 ± 11.85a 11.55 ± 0.05b 176.95 ± 3.38a 10.27 ± 0.74b 167.22 ± 10.93a 9.62 ± 0.88b 
Ellagic acid-galloyl-
hexoside 15.40 ± 0.89
a
 n.d. 36.85 ± 1.42b 4.34 ± 0.14c 13.54 ± 0.50a n.d. 
HHDP-galloyl-
hexose 52.28 ± 3.97
a
 n.d. 81.62 ± 3.34b 18.32 ± 0.56c 46.72 ± 2.28a n.d. 
Curcuminoids 
Bisdemethoxy-
curcumin ** n.d. n.d. n.d. n.d. 398.45 ± 7.45
a
 0.81 ± 0.08b 
Demethoxy-
curcumin ** n.d. n.d. n.d. n.d. 284.97 ± 4.59
a
 1.48 ± 0.03b 
Curcumin ** n.d. n.d. n.d. n.d. 257.07 ± 1.62a n.d. 
< LOQ means the compound was detected but it was below the limit of quantification; n.d. means not detected 
** mean the compounds were detected only turmeric dark chocolate.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Flavones were quantified as quercetin-3-O-rutinoside equivalent. 
Ellagitannins were quantified as ellagic acid equivalent. 
Curcuminoids were quantified as curcumin equivalent. 
Data from chemical extraction were from Martini et al. (2018). 
Table 5. Quantitative results (μmol/100 g of chocolate) for hydroxybenzoic acids identified in dark 
chocolate after chemical extraction and after gastro-intestinal digestion. Values represent means ± standard 
deviation of triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
        Hydroxybenzoic acids 
Hydroxybenzoic 
acid isomer  1.36 ± 0.06
a
 0.58 ± 0.09b 1.30 ± 0.26a 0.45 ± 0.06b 1.75 ± 0.13c 0.60 ± 0.02b 
Hydroxybenzoic 
acid isomer 0.84 ± 0.06
a
 0.60 ± 0.05a 0.52 ± 0.06a 0.63 ± 0.04a 2.66 ± 0.13b 0.83 ± 0.01a 
Hydroxybenzoic 
acid isomer 35.52 ± 0.19
a
 10.72 ± 0.71b 41.95 ± 0.39c 10.11 ± 0.85b 48.70 ± 3.05c 10.55 ± 0.47c 
Hydroxybenzoic 
acid isomer 2.01 ± 0.06
a
 0.72 ± 0.09b 8.57 ± 0.13c 0.99 ± 0.04b 2.14 ± 0.13a 0.89 ± 0.12b 
Hydroxybenzoic 
acid isomer 4.03 ± 0.26
a
 1.00 ± 0.09b 6.10 ± 0.71c 1.93 ± 0.03d 5.00 ± 0.19c 0.98 ± 0.12b 
Protocatechuic 
acid 69.87 ± 1.95
a
 34.75 ± 2.09b 59.16 ± 0.58c 21.58 ± 0.86d 118.90 ± 6.30e 29.02 ± 1.76b 
Vanillic acid isomer 2.53 ± 0.2 a 2.58 ± 0.11a 2.40 ± 0.06a 2.88 ± 0.04a 2.92 ± 0.13a 3.11 ± 0.11a 
Vanillic acid isomer 4.87 ± 0.84a 1.01 ± 0.09b 3.57 ± 0.32a 1.25 ± 0.05b 7.27 ± 0.06c 1.14 ± 0.08b 
Gallic acid* n.d. n.d. 0.91 ± 0.01a 1.00 ± 0.02a n.d. n.d. 
Syringic acid  0.84 ± 0.13a 0.63 ± 0.01a 1.69 ± 0.19b 0.96 ± 0.07a 0.91 ± 0.13a 0.95 ± 0.03a 
Protocatechuic 
acid-4-O-hexoside 0.65 ± 0.06
a
 n.d. 2.01 ± 0.19b 1.22 ± 0.09c 1.23 ± 0.01c 0.68 ± 0.01a 
Vanillic acid-4-O-
hexoside isomer 1.62 ± 0.06
a
 1.70 ± 0.07a 1.30 ± 0.13a 1.65 ± 0.20a 1.95 ± 0.06a 2.49 ± 0.18b 
Vanillic acid-4-O-
hexoside isomer 11.49 ± 0.06
a
 5.95 ± 0.24b 10.84 ± 0.14a 6.02 ± 0.19b 17.08 ± 0.06c 6.68 ± 0.41b 
Vanillic acid-4-O-
hexoside isomer 12.47 ± 0.13
a
 2.09 ± 0.13b 7.86 ± 0.06c 2.43 ± 0.26b 11.23 ± 0.01d 2.31 ± 0.14b 
Galloyl glucose 
isomer * n.d. n.d. 1.88 ± 0.10
a
 1.75 ± 0.09a n.d. n.d. 
Galloylquinic acid 
isomer * n.d. n.d. 11.95 ± 0.52
a
 < LOQ n.d. n.d. 
Galloylquinic acid 
isomer * n.d. n.d. 13.57 ± 0.32
a
 18.74 ± 0.98b n.d. n.d. 
Syringic acid-4-O-
hexoside isomer 6.10 ± 0.26
a
 < LOQ 5.26 ± 0.24a < LOQ 6.95 ± 0.06b n.d. 
Syringic acid-4-O-
hexoside isomer 4.81 ± 0.13
a
 4.20 ± 0.27a 4.61 ± 0.26a 4.55 ± 0.28a 6.75 ± 0.71b 4.98 ± 0.24a 
Vanillic acid 
derivative 2.01 ± 0.01
a
 2.71 ± 0.12b 3.18 ± 0.06c 2.38 ± 0.01b 3.64 ± 0.26c 1.97 ± 0.11a 
< LOQ means the compound was detected but it was below the limit of quantification; n.d. means not detected 
* mean the compounds were detected only in green tea dark chocolate.  
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Hydroxybenzoic acids were quantified as protocatechuic acid equivalent. 
Data from chemical extraction were from Martini et al. (2018). 
Table 6. Quantitative results (μmol/100 g of chocolate) for phenolic compounds grouped by classes 
identified in dark chocolate after chemical extraction and after gastro-intestinal digestion. Values represent 
means ± standard deviation of triplicate determination.  
 
Compound 
Dark chocolate 70% Sakura green tea  dark chocolate 70% 
Turmeric  
dark chocolate 70% 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
Chemical 
extraction After digestion 
        
Total flavan-3-ols 1732.09 ± 30.97a 252.07 ± 10.34b 2563.56 ± 50.12c 389.99 ± 7.07d 1857.63 ± 31.02a 251.62 ± 10.03
b
  
Total 
hydroxycinnamic 
acids 
921.67 ± 29.28a 379.05 ± 9.94b 899.48 ± 14.55a 385.20 ± 12.00b 893.29 ± 9.91a 401.85 ± 4.79b  
Total flavonols 21.33 ± 0.35a 0.53 ± 0.02b 48.00 ± 0.64c 10.75 ± 0.24d 18.70 ± 0.79e 0.53 ± 0.01b  
Total other 
phenolics 18.57 ± 0.35
a
 2.90 ± 0.19b 11.65 ± 0.19c 4.80 ± 0.14d 13.70 ± 0.16e 2.24 ± 0.08f  
Total flavones 4.89 ± 0.53a 0.41 ± 0.01b 8.03 ± 0.24c 2.24 ± 0.05d 5.39 ± 0.71a 0.47 ± 0.01b 
Total 
ellagitannins 253.64 ± 12.53
a,d
 11.55 ± 0.05b 295.43 ± 14.96a  32.93 ± 0.94c 227.48 ± 21.17d 9.62 ± 0.88e 
 Total 
hydroxybenzoic 
acids 
161.04 ± 2.20a 70.04 ± 2.25b 188.64 ± 0.19c 80.51 ± 1.64d 239.09 ± 7.05e 67.19 ± 1.91b 
Total 
curcuminoids n.d. n.d. n.d. n.d. 940.48 ± 8.90
a
 2.29 ± 0.09b 
Total phenolic 
compounds 3113.22 ± 44.48
a
 716.55 ± 14.52b 3954.78 ± 52.43c 906.45 ± 14.06d 4195.76 ± 36.26e 735.81 ± 11.31b 
Different superscript letters within the same row indicate that the values are significantly different (P<0.05). 
Data from chemical extraction were from Martini et al. (2018). 
Table 7. Mass spectral and quantitative data of newly formed phenolic compounds identified in 
different dark chocolates after in vitro gastro-intestinal digestion. DC identify dark chocolate; 
GTDC identify dark chocolate enriched with Sakura green tea leaves; TDC identify dark chocolate 
enriched with turmeric powder. Data are expressed as μmol/100 g of chocolate. 
<LOQ means the compound was detected but it was below the limit of quantification.  
n.d. means not detected 
aquantified as coumaric acid equivalent 
bquantified as protocatechuic acid equivalent 
cquantified as epicatechin equivalent 
Compounds Molecular formula 
Exp  
[M-H]- 
Calc 
 [M-H]- 
ppm Fragment 
ions DC GTDC TD 
4-Caffeoylquinic 
acida C16H18O9 353.0951 353.0950 -0.05 
179.0433, 
173.0049 1.10 ± 0.09 1.04 ± 0.02 1.20 ± 0.04 
Trihydroxybenzeneb C6H6O3 125.0311 125.0317 4.71 81.0290 0.19 ± 0.01 0.45 ± 0.03 0.21 ± 0.02 
Theasinensin 
isomerc C30H26O14 609.1335 609.1322 -2.04 
471.0657, 
453.0536, 
427.0777, 
333.0453, 
167.0299 
n.d. 0.73 ± 0.04 n.d. 
Epigallocatechin 
dimer isomers  
(P2-analogue)c 
C29H24O13 579.1198 579.1216 3.26 
543.1247, 
423.1119, 
405.0840, 
167.0453, 
125.0292 
n.d. <LOQ n.d. 
Table 8. Phenolic compounds identified in the cell media after 24 h of incubation with Caco-2 and 
SW480 of dark chocolate phenolic-rich fraction extracted at the end of the in vitro digestion. Data 
are expressed as μmol/100 g of chocolate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<LOQ means the compound was detected but it was below the limit of quantification.  
n.d. means not detected 
aquantified as ferulic acid equivalent 
bquantified as coumaric acid equivalent 
cquantified as caffeic acid equivalent 
dquantified as quercetin-3-O-glucoside equivalent 
equantified as ellagic acid equivalent 
Compounds [M-H]- Fragment ions Caco-2 SW480 
     
Catechin 289 245 < LOQ < LOQ 
Epicatechin 289 245 < LOQ < LOQ 
Methyl-(epi)catechin 303 288 < LOQ < LOQ 
Di-methyl-(epi)catechin 317 287 < LOQ n.d. 
Ferulic acida 193 178 34.91 ± 1.67 9.87 ± 0.27 
Feruloyl-aspartatea 308 290, 264, 246, 220 < LOQ 1.69 ± 0.02 
Dihydro-ferulic acida 195 177, 136 4.25 ± 0.25 n.d. 
Coumaric acidb 163 119 86.14 ± 3.19 96.80 ± 4.96 
Coumaroyl-sulphate 243 163, 158, 119 n.d. < LOQ 
Dihydro-coumaric acidb 165 147, 119 n.d. 9.41 ± 0.58 
Caffeic acidc 179 135 n.d. 1.00 ± 0.06 
Quercetin-glucosided 463 301, 179, 151 n.d. 0.31 ± 0.01 
Quercetin-pentosided 433 301, 179, 151 < LOQ 0.16 ± 0.01 
Quercetind 301 271, 255 0.06 ± 0.01 n.d. 
Methyl-ellagic acide 315 257, 229 n.d. 0.40 ± 0.02 
